BioTheryX | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights

6 August 2024

Nuvalent’s next battleground is HER2

NVL-330 features among the latest crop of industry projects newly into human trials.

Subscribe to BioTheryX